Pricing Log in Create free account
Friday 6 November 2026 Export BLCO’s income statement to Excel — free account

Bausch + Lomb Corporation

BLCO Healthcare Medical Instruments & Supplies

Bausch + Lomb Corporation’s revenue for fiscal 2025 (year ended December 2025) was $5.1 billion, up 6.47% from fiscal 2024.

Revenue
+7.34%
EPS
+222.4%
Free cash flow
+182.5%
Total debt
+2.93%

Quarter to September 2026, against a year earlier

19.94 0.66 −3.20%
Market cap
$7.1B
P/E
0.0×
Fwd P/E
749×
Dividend yield
—
F-score
3/9
Altman Z
0.87
Beneish M
−2.52
Dividend safety
n/a
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

Bausch + Lomb Corporation (BLCO) EV/EBITDA

Alert me on EV/EBITDA

As of 5 November 2026, Bausch + Lomb Corporation (BLCO) trades at a EV/EBITDA of 14.6×. Over the past ten years it has ranged from 9.6× (June 2022) to 21.0× (September 2025); the current reading is higher than 27% of that period. That is in line with the Medical Instruments & Supplies industry median of 14.9× and above the Healthcare sector median of 8.4×.

EV/EBITDA, daily

Embed this chart

Annual newest first

Period EV/EBITDA Change
FY2025 19.4× 10.99%
FY2024 17.5× (6.57%)
FY2023 18.7× 47.30%
FY2022 12.7× (1.08%)
FY2021 12.9× 0.00%
FY2020 12.9× —

Quarterly newest first

Period EV/EBITDA Change
Sep 2026 13.3× (6.42%)
Jun 2026 14.2× (9.96%)
Mar 2026 15.8× (18.74%)
Dec 2025 19.4× 4.44%
19 more quarters

Against its own ten years

Low 9.6× High 21.0×
Ten-year median 16.7×
Current reading's percentile 27

EV/EBITDA against peers

Company EV/EBITDA
MMED MiniMed Group, Inc. compare n/m
ALGN Align Technology, Inc. compare 12.6×
ATR AptarGroup, Inc. compare 13.2×
BLCO Bausch + Lomb Corporation 14.6×
AVTR Avantor, Inc. compare 14.7×
MMSI Merit Medical Systems, Inc. compare 15.5×
COO The Cooper Companies, Inc. compare 15.8×
TFX Teleflex Incorporated compare 35.7×
RGEN Repligen Corporation compare 60.1×
Medical Instruments & Supplies industry median 14.9×
Healthcare sector median 8.4×
Market median 10.9×

What EV/EBITDA is

Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)

The full definition of EV/EBITDA →

More on BLCO